Caroline Robert (C Robert)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 48

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature communications

Nature medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

Gustave Roussy (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Gustave Roussy

France

PHD :: Dermatology

Publications

Jason John Luke, Paolo Antonio Ascierto, Muhammad A Khattak, Luis de la Cruz Merino, Michele Del Vecchio, Piotr Lukasz Rutkowski, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion Sileni, Joanne M Jeter, Caroline Robert, Jean-Jacques Grob, Federica de Galitiis, Dirk Schadendorf, Matteo S Carlino, Xi Lawrence Wu, Mizuho Kalabis, Clemens Krepler, Alexander M M Eggermont, Georgina V Long
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Jason John Luke, Paolo Antonio Ascierto, Muhammad A Khattak, Luis de la Cruz Merino, Michele Del Vecchio, Piotr Lukasz Rutkowski, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion Sileni, Joanne M Jeter, Caroline Robert, Jean-Jacques Grob, Federica de Galitiis, Dirk Schadendorf, Matteo S Carlino, Xi Lawrence Wu, Mizuho Kalabis, Clemens Krepler, Alexander M M Eggermont, Georgina V Long
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Jason John Luke, Paolo Antonio Ascierto, Muhammad A Khattak, Luis de la Cruz Merino, Michele Del Vecchio, Piotr Lukasz Rutkowski, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion Sileni, Joanne M Jeter, Caroline Robert, Jean-Jacques Grob, Federica de Galitiis, Dirk Schadendorf, Matteo S Carlino, Xi Lawrence Wu, Mizuho Kalabis, Clemens Krepler, Alexander M M Eggermont, Georgina V Long
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Mariangela Russo, Mengnuo Chen, Elisa Mariella, Haoning Peng, Sumaiyah K Rehman, Elena Sancho, Alberto Sogari, Tzen S Toh, Nathalie Q Balaban, Eduard Batlle, René Bernards, Mathew J Garnett, Matthew Hangauer, Eleonora Leucci, Jean-Christophe Marine, Catherine A O'Brien, Yaara Oren, E Elizabeth Patton, Caroline Robert, Susan M Rosenberg, Shensi Shen, Alberto Bardelli
Cancer drug-tolerant persister cells: from biological questions to clinical opportunities. Nature reviews. Cancer (2024)
Jason John Luke, Paolo Antonio Ascierto, Muhammad A Khattak, Luis de la Cruz Merino, Michele Del Vecchio, Piotr Lukasz Rutkowski, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion Sileni, Joanne M Jeter, Caroline Robert, Jean-Jacques Grob, Federica de Galitiis, Dirk Schadendorf, Matteo S Carlino, Xi Lawrence Wu, Mizuho Kalabis, Clemens Krepler, Alexander M M Eggermont, Georgina V Long
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jason John Luke, Paolo Antonio Ascierto, Muhammad A Khattak, Luis de la Cruz Merino, Michele Del Vecchio, Piotr Lukasz Rutkowski, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion Sileni, Joanne M Jeter, Caroline Robert, Jean-Jacques Grob, Federica de Galitiis, Dirk Schadendorf, Matteo S Carlino, Xi Lawrence Wu, Mizuho Kalabis, Clemens Krepler, Alexander M M Eggermont, Georgina V Long
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Andrey A Yurchenko, Fatemeh Rajabi, Tirzah Braz-Petta, Hiva Fassihi, Alan Lehmann, Chikako Nishigori, Jinxin Wang, Ismael Padioleau, Konstantin Gunbin, Leonardo Panunzi, Fanny Morice-Picard, Pierre Laplante, Caroline Robert, Patricia L Kannouche, Carlos Frederico Martins Menck, Alain Sarasin, Sergey I Nikolaev
Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients. Nature communications 14 (1) (2023)
Caroline Robert, Celeste Lebbè, Thierry Lesimple, Eija Lundström, Valérie Nicolas, Bruno Gavillet, Philippa Crompton, Baryour Baroudijian, Émilie Routier, Ferdy J Lejeune
Phase I Study of Androgen Deprivation Therapy in Combination with Anti-PD-1 in Melanoma Patients Pretreated with Anti-PD-1. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (5) (2023)
Caroline Robert, Stéphan Vagner, Xavier Mariette
Using genetics to predict toxicity of cancer immunotherapy. Nature medicine 28 (12) (2023)
Paolo Antonio Ascierto, Reinhard Dummer, Helen J Gogas, Ana Arance, Mario Mandala, Gabriella Liszkay, Claus Garbe, Dirk Schadendorf, Ivana Krajsova, Ralf Gutzmer, Vanna Chiarion Sileni, Caroline Dutriaux, Jan Willem B de Groot, Naoya Yamazaki, Carmen Loquai, Caroline Robert, Keith T Flaherty
Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF -Mutant Melanoma: Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Andrey A Yurchenko, Fatemeh Rajabi, Tirzah Braz-Petta, Hiva Fassihi, Alan Lehmann, Chikako Nishigori, Jinxin Wang, Ismael Padioleau, Konstantin Gunbin, Leonardo Panunzi, Fanny Morice-Picard, Pierre Laplante, Caroline Robert, Patricia L Kannouche, Carlos Frederico Martins Menck, Alain Sarasin, Sergey I Nikolaev
Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients. Nature communications 14 (1) (2023)
Andrey A Yurchenko, Fatemeh Rajabi, Tirzah Braz-Petta, Hiva Fassihi, Alan Lehmann, Chikako Nishigori, Jinxin Wang, Ismael Padioleau, Konstantin Gunbin, Leonardo Panunzi, Fanny Morice-Picard, Pierre Laplante, Caroline Robert, Patricia L Kannouche, Carlos Frederico Martins Menck, Alain Sarasin, Sergey I Nikolaev
Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients. Nature communications 14 (1) (2023)
Caroline Robert, Stéphan Vagner, Xavier Mariette
Using genetics to predict toxicity of cancer immunotherapy. Nature medicine 28 (12) (2023)
Andrey A Yurchenko, Fatemeh Rajabi, Tirzah Braz-Petta, Hiva Fassihi, Alan Lehmann, Chikako Nishigori, Jinxin Wang, Ismael Padioleau, Konstantin Gunbin, Leonardo Panunzi, Fanny Morice-Picard, Pierre Laplante, Caroline Robert, Patricia L Kannouche, Carlos Frederico Martins Menck, Alain Sarasin, Sergey I Nikolaev
Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients. Nature communications 14 (1) (2023)
Rahul Seth, Sanjiv S Agarwala, Hans Messersmith, Krishna C Alluri, Paolo Antonio Ascierto, Michael B Atkins, Kathryn Bollin, Matías Chacón, Nancy B Davis, Mark B Faries, Pauline Funchain, Jason S Gold, Samantha Guild, David E Gyorki, Varinder Kaur, Nikhil I Khushalani, Joanne M Jeter, Jennifer Leigh McQuade, Michael O Meyers, Anthony Provenzano, Caroline Robert, Mario Santinami, Amikar Sehdev, Vernon K Sondak, Gilliosa Spurrier, Umang Swami, Thach-Giao Truong, Katy K Tsai, Alexander C J van Akkooi, Jeffrey S Weber
Systemic Therapy for Melanoma: ASCO Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Yi Pu, Lu Li, Haoning Peng, Lunxu Liu, Dominique Heymann, Caroline Robert, François Vallette, Shensi Shen
Drug-tolerant persister cells in cancer: the cutting edges and future directions. Nature reviews. Clinical oncology (2023)
Andrey A Yurchenko, Fatemeh Rajabi, Tirzah Braz-Petta, Hiva Fassihi, Alan Lehmann, Chikako Nishigori, Jinxin Wang, Ismael Padioleau, Konstantin Gunbin, Leonardo Panunzi, Fanny Morice-Picard, Pierre Laplante, Caroline Robert, Patricia L Kannouche, Carlos Frederico Martins Menck, Alain Sarasin, Sergey I Nikolaev
Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients. Nature communications 14 (1) (2023)
Claus Garbe, Reinhard Dummer, Teresa Amaral, Rodabe N Amaria, Paolo Antonio Ascierto, Elizabeth M Burton, Brigitte Dreno, Alexander M M Eggermont, Axel Hauschild, Christoph Hoeller, Roland Kaufmann, Celeste Lebbè, Mario Mandala, Alexander M Menzies, David Moreno, Olivier Michielin, Paul Nathan, Sapna Pradyuman Patel, Caroline Robert, Dirk Schadendorf, Paul C Lorigan, Richard A Scolyer, Hussein A Tawbi, Bart A van de Wiel, Christian U Blank, Georgina V Long
Neoadjuvant immunotherapy for melanoma is now ready for clinical practice. Nature medicine (2023)
Caroline Robert, Matteo S Carlino, Catriona McNeil, Antoni Ribas, Jean-Jacques Grob, Jacob Schachter, Marta Nyakas, Damien Kee, Teresa M Petrella, Arnold Blaustein, Michal Lotem, Ana Arance, Adil I Daud, Omid Hamid, James M G Larkin, James Anderson, Clemens Krepler, Dmitri Grebennik, Georgina V Long
Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Caroline Robert, Stéphan Vagner, Xavier Mariette
Using genetics to predict toxicity of cancer immunotherapy. Nature medicine 28 (12) (2023)
Céline Boutros, Djaouida Belkadi-Sadou, Antoine Marchand, Séverine Roy, Emilie Routier, Caroline Robert
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma. Current oncology reports (2023)
Reinhard Dummer, Keith T Flaherty, Caroline Robert, Ana M Arance, Jan Willem B de Groot, Claus Garbe, Helen J Gogas, Ralf Gutzmer, Ivana Krajsová, Gabriella Liszkay, Carmen Loquai, Mario Mandala, Dirk Schadendorf, Naoya Yamazaki, Alessandra di Pietro, Jean Cantey-Kiser, Michelle Edwards, Paolo Antonio Ascierto
COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF V600-Mutant Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Andrey A Yurchenko, Oltin Tiberiu Pop, Meriem Ighilahriz, Ismael Padioleau, Fatemeh Rajabi, Hayley J Sharpe, Nicolas Poulalhon, Brigitte Dreno, Amir Khammari, Marc Delord, Antonio Alberti, Nadem Soufir, Maxime Battistella, Samia Mourah, Fanny Bouquet, Ariel Savina, Andrej Besse, Max Mendez-Lopez, Florent Grange, Sandrine Monestier, Laurent Mortier, Nicolas Meyer, Caroline Dutriaux, Caroline Robert, Philippe Saiag, Florian Herms, Jerome Lambert, Frederic J de Sauvage, Nicolas Dumaz, Lukas Flatz, Nicole Basset-Seguin, Sergey I Nikolaev
Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (7) (2022)
Caroline Robert
LAG-3 and PD-1 blockade raises the bar for melanoma. Nature cancer 2 (12) (2022)
Reinhard Dummer, Georgina V Long, Caroline Robert, Hussein A Tawbi, Keith T Flaherty, Paolo Antonio Ascierto, Paul D Nathan, Piotr Lukasz Rutkowski, Oleg Leonov, Caroline Dutriaux, Mario Mandala, Paul C Lorigan, Pier Francesco Ferrucci, Jean-Jacques Grob, Nicolas Meyer, Helen J Gogas, Daniil Stroyakovskiy, Ana M Arance, Jan C Brase, Steven Green, Tomas Haas, Aisha Masood, Eduard Gasal, Antoni Ribas, Dirk Schadendorf
Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600-Mutant Unresectable or Metastatic Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (13) (2022)
Jeffrey S Weber, Dirk Schadendorf, Michele Del Vecchio, James M G Larkin, Victoria Atkinson, Michael Schenker, Jacopo Pigozzo, Helen J Gogas, Stéphane Dalle, Nicolas Meyer, Paolo Antonio Ascierto, Shahneen Sandhu, Thomas Eigentler, Ralf Gutzmer, Jessica C Hassel, Caroline Robert, Matteo S Carlino, Anna Maria Di Giacomo, Marcus O Butler, Eva Muñoz Couselo, Michael P Brown, Piotr Lukasz Rutkowski, Andrew M Haydon, Jean-Jacques Grob, Jacob Schachter, Paola Queirolo, Luis de la Cruz Merino, Andre van der Westhuizen, Alexander M Menzies, Sandra Re, Tuba Bas, Veerle de Pril, Julia Braverman, Daniel J Tenney, Hao Tang, Georgina V Long
Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Caroline Robert, Celeste Lebbè, Thierry Lesimple, Eija Lundström, Valérie Nicolas, Bruno Gavillet, Philippa Crompton, Baryour Baroudijian, Émilie Routier, Ferdy J Lejeune
Phase I study of Androgen deprivation therapy in combination with anti-PD-1 in patients pre- treated with anti-PD-1. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Giuseppina Claps, Sara Faouzi, Virginie Quidville, Feras Chehade, Shensi Shen, Stéphan Vagner, Caroline Robert
The multiple roles of LDH in cancer. Nature reviews. Clinical oncology 19 (12) (2022)
Olivier Mir, Marie Ferrua, Aude Fourcade, Delphine Mathivon, Adeline Duflot-Boukobza, Sarah Dumont, Eric Baudin, Suzette Delaloge, David Malka, Laurence Albiges, Patricia Pautier, Caroline Robert, David Planchard, Stéphane de Botton, Florian Scotté, François Lemare, May Abbas, Marilène Guillet, Vanessa Puglisi, Mario Di Palma, Etienne Minvielle
Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial. Nature medicine 28 (6) (2022)
Caroline Robert, Stéphan Vagner, Xavier Mariette
Using genetics to predict toxicity of cancer immunotherapy. Nature medicine (2022)
James S Wilmott, Hussein A Tawbi, Johnathan A Engh, Nduka M Amankulor, Brindha Shivalingam, Hiya Banerjee, Ismael A Vergara, Hansol Lee, Peter A Johansson, Peter M Ferguson, Philippe Saiag, Caroline Robert, Jean-Jacques Grob, Lisa H Butterfield, Richard A Scolyer, Joanne M Jeter, Georgina V Long, Michael A Davies
Clinical features associated with outcomes and biomarker analysis of dabrafenib plus trametinib treatment in patients with BRAF-mutant melanoma brain metastases. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Dirk Schadendorf, Reinhard Dummer, Caroline Robert, Antoni Ribas, Ryan J Sullivan, Timothy Panella, Meredith A McKean, Edgardo S Santos, Kimberli Brill, Anna Polli, Alessandra di Pietro, Paolo Antonio Ascierto
STARBOARD: encorafenib + binimetinib + pembrolizumab for first-line metastatic/unresectable BRAF V600-mutant melanoma. Future oncology (London, England) 18 (17) (2022)
Y Miao, F Kolb, G Tomasic, J Lupu, E Routier, Caroline Robert
Keratoacanthoma or cutaneous squamous cell carcinoma revealing a DNA mismatch repair default (Muir-Torre Syndrome). Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Georgina V Long, Caroline Robert, Marcus O Butler, Felix Couture, Matteo S Carlino, Steven O'Day, Victoria Atkinson, Jonathan S Cebon, Michael P Brown, Stéphane Dalle, Andrew G Hill, Geoffrey T Gibney, Steven McCune, Alexander M Menzies, Cuizhen Niu, Nageatte Ibrahim, Blanca Homet Moreno, Adi Diab
Standard-Dose Pembrolizumab Plus Alternate-Dose Ipilimumab in Advanced Melanoma: KEYNOTE-029 Cohort 1C, a Phase 2 Randomized Study of Two Dosing Schedules. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Alexander M M Eggermont, Christian U Blank, Mario Mandala, Georgina V Long, Victoria G Atkinson, Stéphane Dalle, Andrew M Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S Carlino, Shahneen Sandhu, James M G Larkin, Susana Puig Sardà, Paolo Antonio Ascierto, Piotr Rutkowski, Dirk Schadendorf, Rutger Koornstra, Leonel Hernandez-Aya, Anna Maria Di Giacomo, Alfonsus J M van den Eertwegh, Jean-Jacques Grob, Ralf Gutzmer, Rahima Jamal, Paul C Lorigan, Alexander C J van Akkooi, Clemens Krepler, Nageatte Ibrahim, Sandrine Marreaud, Michal Kicinski, Stefan Suciu, Caroline Robert
Reply to E. Hindié. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (8) (2021)
Isabelle Girault, Julien Adam, Shensi Shen, Séverine Roy, Caroline Brard, Sara Faouzi, Emilie Routier, Jeremy Lupu, Sarah Warren, Kristina Sorg, SuFey Ong, Pascale Morel, Jean Yves Scoazec, Stéphan Vagner, Caroline Robert
A PD-1 /PD-L1 proximity assay as a theranostic marker for PD-1 blockade in patients with metastatic melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Jan C Brase, Robert F H Walter, Alexander Savchenko, Daniel Gusenleitner, James Garrett, Tobias Schimming, Renata Varaljai, Deborah Castelletti, Ju Kim, Naveen Dakappagari, Ken Schultz, Caroline Robert, Georgina V Long, Paul D Nathan, Antoni Ribas, Keith T Flaherty, Boguslawa Karaszewska, Jacob Schachter, Antje Sucker, Kurt W Schmid, Lisa Zimmer, Elisabeth Livingstone, Eduard Gasal, Dirk Schadendorf, Alexander Roesch
Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (16) (2021)
Lucilla Fabbri, Alina Chakraborty, Caroline Robert, Stéphan Vagner
The plasticity of mRNA translation during cancer progression and therapy resistance. Nature reviews. Cancer 21 (9) (2021)
Filippo G Dall'Olio, Aurélien Marabelle, Caroline Caramella, Camilo Garcia, Mihaela Aldea, Nathalie Chaput, Caroline Robert, Benjamin Besse
Tumour burden and efficacy of immune-checkpoint inhibitors. Nature reviews. Clinical oncology (2021)
Michaël Cerezo, Caroline Robert, Lun-Xu Liu, Shensi Shen
The Role of mRNA Translational Control in Tumor Immune Escape and Immunotherapy Resistance. Cancer research 81 (22) (2021)
Luca Di Leo, Valérie Bodemeyer, Francesca M Bosisio, Giuseppina Claps, Marco Carretta, Salvatore Rizza, Fiorella Faienza, Alex Frias, Shawez Khan, Matteo Bordi, Maria P Pacheco, Julie S Di Martino, Jose J Bravo-Cordero, Colin J Daniel, Rosalie C Sears, Marco Donia, Daniel H Madsen, Per Guldberg, Giuseppe Filomeni, Thomas Sauter, Caroline Robert, Daniela De Zio, Francesco Cecconi
Loss of Ambra1 promotes melanoma growth and invasion. Nature communications 12 (1) (2021)
Léa Dousset, Florence Poizeau, Caroline Robert, Sandrine Mansard, Laurent Mortier, Charline Caumont, Émilie Routier, Alain Dupuy, Jacques Rouanet, Maxime Battistella, Anna Greliak, David Cappellen, Marie-Dominique Galibert, Clara Allayous, Alexandra Lespagnol, Emilie Gérard, Inès Kerneuzet, Séverine Roy, Caroline Dutriaux, Jean-Philippe Merlio, Beatrice Vergier, Alexa B Schrock, Jessica Lee, Siraj M Ali, Solène-Florence Kammerer-Jacquet, Celeste Lebbè, Marie Beylot-Barry, Lise Boussemart
Positive Association Between Location of Melanoma, Ultraviolet Signature, Tumor Mutational Burden, and Response to Anti-PD-1 Therapy. JCO precision oncology 5 (2021)
Clélia Coutzac, Jean-Mehdi Jouniaux, Angelo Paci, Julien Schmidt, Domenico Mallardo, Atmane Seck, Vahe Asvatourian, Lydie Cassard, Patrick Saulnier, Ludovic Lacroix, Paul-Louis Woerther, Aurore Vozy, Marie Naigeon, Laetitia Nebot-Bral, Mélanie Desbois, Ester Simeone, Christine Mateus, Lisa Boselli, Jonathan Grivel, Emilie Soularue, Patricia Lepage, Franck Carbonnel, Paolo Antonio Ascierto, Caroline Robert, Nathalie Chaput
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer. Nature communications 11 (1) (2020)
Alexander M M Eggermont, Christian U Blank, Mario Mandala, Georgina V Long, Victoria G Atkinson, Stéphane Dalle, Andrew M Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S Carlino, Shahneen Sandhu, James M G Larkin, Susana Puig, Paolo Antonio Ascierto, Piotr Rutkowski, Dirk Schadendorf, Rutger Koornstra, Leonel Hernandez-Aya, Anna Maria Di Giacomo, Alfonsus J M van den Eertwegh, Jean-Jacques Grob, Ralf Gutzmer, Rahima Jamal, Paul C Lorigan, Alexander C J van Akkooi, Clemens Krepler, Nageatte Ibrahim, Sandrine Marreaud, Michal Kicinski, Stefan Suciu, Caroline Robert
Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (33) (2020)
Caroline Robert, Georgina V Long, Benjamin Brady, Caroline Dutriaux, Anna Maria Di Giacomo, Laurent Mortier, Piotr Rutkowski, Jessica C Hassel, Catriona M McNeil, Ewa Anna Kalinka, Celeste Lebbè, Julie Charles, Micaela M Hernberg, Kerry Joane Savage, Vanna Chiarion Sileni, Catalin Mihalcioiu, Cornelia Mauch, Ana Arance, Francesco Cognetti, Lars Ny, Henrik Schmidt, Dirk Schadendorf, Helen J Gogas, Jesús Zoco, Sandra Re, Paolo Antonio Ascierto, Victoria Atkinson
Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (33) (2020)
Reinhard Dummer, Celeste Lebbé, Victoria Atkinson, Mario Mandalà, Paul D Nathan, Ana Arance, Erika Richtig, Naoya Yamazaki, Caroline Robert, Dirk Schadendorf, Hussein A Tawbi, Paolo Antonio Ascierto, Antoni Ribas, Keith T Flaherty, Neha Pakhle, Catarina D Campbell, Daniel Gusenleitner, Aisha Masood, Jan C Brase, Eduard Gasal, Georgina V Long
Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i. Nature medicine 26 (10) (2020)
Caroline Robert, Aurélien Marabelle, Hugo Herrscher, Caroline Caramella, Pascal Rouby, Karim Fizazi, Benjamin Besse
Immunotherapy discontinuation - how, and when? Data from melanoma as a paradigm. Nature reviews. Clinical oncology 17 (11) (2020)
Caroline Robert
A decade of immune-checkpoint inhibitors in cancer therapy. Nature communications 11 (1) (2020)

Caroline Robert.css-eqlu8i{font-size:small;padding-left:4px;} (C Robert)

Publication Activity (10 Years)

Top Topics

Top Venues

Caroline Robert (C Robert)